MEDICINOVA INC
MEDICINOVA INC (MNOV): 4 pipeline candidates · 1 upcoming catalyst · ~24 mo cash runway · 4 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
23.8 months
D/E 0.08 · 0% dilution
Lead: Phase 2/Phase 3
4 candidates
1 upcoming, next in ~653d
N/A
A transparent, data-derived signal for MEDICINOVA INCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$61.5M
Cash
$27.3M
Quarterly Burn
$3.5M
Runway
23.8 mo
Revenue
$187K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
29
Total value held
$7.9M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 1,222,078 | $1.7M |
| essex woodlands management, inc. | 1,105,941 | $1.5M |
| blackrock, inc. | 705,954 | $967K |
| citigroup inc | 635,715 | $871K |
| geode capital management, llc | 543,843 | $745K |
| vanguard fiduciary trust co | 280,621 | $384K |
| state street corp | 193,698 | $265K |
| renaissance technologies llc | 189,900 | $260K |
| barclays plc | 162,900 | $223K |
| northern trust corp | 133,163 | $182K |
Showing top 10 of 29 institutional holders of MEDICINOVA INC. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in MEDICINOVA INC's pipeline?
MEDICINOVA INC (MNOV) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is MEDICINOVA INC's lead drug candidate?
MEDICINOVA INC's most advanced tracked candidate is mn-001 (Phase 2) for Diabetes Mellitus, Type 2; Idiopathic Pulmonary Fibrosis.
What is MEDICINOVA INC's next catalyst?
MEDICINOVA INC's next tracked catalyst is a Phase3_Topline event — "Phase 3 Topline: A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 12 Month Clinical Trial to" — expected April 1, 2028.
What is MEDICINOVA INC's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, MEDICINOVA INC has approximately 23.8 months of cash runway.
What is MEDICINOVA INC's market capitalization?
MEDICINOVA INC's market capitalization is approximately $61.5M.
Get the full picture on MEDICINOVA INC
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.